We are live on ! Find out more
NCM

Nantahala Capital Management Portfolio holdings

AUM $2.72B
1-Year Est. Return 121.58%
This Fund
S&P 500
This Quarter Est. Return
-17.59%
1 Year Est. Return
+121.58%
3 Year Est. Return
+308.64%
5 Year Est. Return
+308.9%
10 Year Est. Return
+2,888.73%
AUM
$1.99B
AUM Growth
-$266M
Cap. Flow
+$200M
Cap. Flow %
10.03%
Top 10 Hldgs %
49.64%
Holding
139
New
17
Increased
34
Reduced
53
Closed
15

Top Buys

Rank Stock Value
1
COST icon
Costco
COST
+$36.3M
2
PTON icon
Peloton Interactive
PTON
+$29.8M
3
RH icon
RH
RH
+$26.7M
4
MAX icon
MediaAlpha
MAX
+$14.7M
5
LYRA
LYRA THERAPEUTICS INC
LYRA
+$12.9M

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$63.4M
2
IMXI icon
International Money Express
IMXI
+$29.4M
3
FTVI
FinTech Acquisition Corp. VI Class A Common Stock
FTVI
+$9.82M
4
GDEN
Golden Entertainment
GDEN
+$9.68M
5
FTCV
FinTech Acquisition Corp. V Class A Common Stock
FTCV
+$9.46M

Sector Composition

Rank Sector Weight
1 Healthcare 24.19%
2 Consumer Discretionary 12.79%
3 Industrials 5.34%
4 Financials 4.07%
5 Communication Services 3.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HERA
51
DELISTED
FTAC Hera Acquisition Corp. Class A Ordinary Shares
HERA
$7.71M 0.39%
787,130
-12,871
-2% -$126K
FBIO icon
52
Fortress Biotech
FBIO
$91.4M
$7.36M 0.37%
583,910
-5,592
-0.9% -$82.9K
CNCE
53
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$6.99M 0.35%
+1,659,840
New +$6.57M
SRL icon
54
Scully Royalty
SRL
$89.4M
$6.19M 0.31%
771,196
-1,241
-0.2% -$11.2K
TSHA icon
55
Taysha Gene Therapies
TSHA
$1.83B
$6.11M 0.31%
1,643,438
+309,491
+23% +$1.23M
PRDO icon
56
PUT
Perdoceo Education
PRDO
$1.97B
$5.89M 0.3%
+500,000
New +$5.48M
SPRY icon
57
ARS Pharmaceuticals
SPRY
$587M
$5.88M 0.29%
1,386,138
+472,541
+52% +$1.65M
APEN
58
CALL
DELISTED
Apollo Endosurgery, Inc.
APEN
$5.84M 0.29%
+1,600,000
New +$7.56M
ONTF
59
DELISTED
ON24
ONTF
$5.41M 0.27%
570,403
+186,315
+49% +$2.26M
APTO
60
DELISTED
Aptose Biosciences, Inc.
APTO
$5.37M 0.27%
16,073
-199
-1% -$95.2K
GYRE icon
61
Gyre Therapeutics
GYRE
$749M
$4.91M 0.25%
367,454
+44,682
+14% +$297K
AURA icon
62
Aura Biosciences
AURA
$796M
$4.86M 0.24%
343,215
+41,225
+14% +$682K
SYK icon
63
Stryker
SYK
$133B
$4.58M 0.23%
+23,000
New +$5.4M
SSKN
64
DELISTED
Strata Skin Sciences
SSKN
$4.4M 0.22%
457,581
– –
IWM icon
65
iShares Russell 2000 ETF
IWM
$81.5B
$4.04M 0.2%
23,873
-344,156
-94% -$63.4M
CRIS icon
66
Curis
CRIS
$7.13M
$3.57M 0.18%
9,070
+2,874
+46% +$1.2M
INMD icon
67
InMode
INMD
$873M
$3.54M 0.18%
+158,154
New +$4.16M
AVTX icon
68
Avalo Therapeutics
AVTX
$1.06B
$3.35M 0.17%
2,330
-48
-2% -$64.2K
AKU
69
DELISTED
Akumin Inc
AKU
$3.33M 0.17%
5,545,233
-33,759
-0.6% -$30.2K
RILY icon
70
BRC Group Holdings
RILY
$292M
$3.26M 0.16%
77,083
-1,425
-2% -$74.8K
ARYD
71
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
$3.17M 0.16%
322,929
-2,919
-0.9% -$28.6K
FAZE
72
DELISTED
FaZe Holdings Inc. Common Stock
FAZE
$2.96M 0.15%
297,727
-4,059
-1% -$40.1K
RDNW
73
RideNow Group
RDNW
$248M
$2.94M 0.15%
+200,000
New +$3.91M
PWP icon
74
Perella Weinberg Partners
PWP
$1.26B
$2.93M 0.15%
502,676
– –
MACK
75
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$2.92M 0.15%
491,509
-25,308
-5% -$143K
1 2
3
4 5

Similar funds

TAM
Timucuan Asset Management Jacksonville, Florida $2.72B AUM 4.95% 1-Year Est. Return
XL
XN LP New York $2.72B AUM 46.67% 1-Year Est. Return
NB
Nicolet Bankshares Green Bay, Wisconsin $2.71B AUM 17.55% 1-Year Est. Return
PA
Profund Advisors Bethesda, Maryland $2.72B AUM 47.27% 1-Year Est. Return
BCM
Bowie Capital Management Richardson, Texas $2.71B AUM 5.42% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.57% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
GC
Giverny Capital Montreal, Quebec, Canada $2.73B AUM 14.09% 1-Year Est. Return

Nantahala Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Nantahala Capital Management held 139 positions worth $1.99B, down 12% from $2.26B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Nantahala Capital Management deployed $200M of net new capital in Q2 2022, opening 17 new positions and adding to 34 existing holdings. Its largest new stake was Costco: 71,495 shares worth $34.3M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $63.4M trimmed.

  • Nantahala Capital Management's largest Q2 2022 buy was Costco: 71,495 shares worth $34.3M.
  • Nantahala Capital Management added most to Peloton Interactive in Q2 2022, an estimated $29.8M increase.
  • Nantahala Capital Management's biggest Q2 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $63.4M.
  • Nantahala Capital Management fully exited International Money Express in Q2 2022, selling an estimated $29.4M.
  • Nantahala Capital Management's ten largest holdings make up 50% of its $1.99B portfolio in Q2 2022.
  • Nantahala Capital Management opened 17 new positions and closed 15 in Q2 2022.
  • Nantahala Capital Management's portfolio value fell 12% quarter-over-quarter to $1.99B.

Based on Nantahala Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.